This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Hexacath, Coroventis Research Ab. Active years: 2020-2024.
Company Filing History:
Years Active: 2020-2024
Title: Innovations by Bernard De Bruyne
Introduction
Bernard De Bruyne is a notable inventor based in Kraainem, Belgium. He has made significant contributions to the field of medical technology, particularly in the area of cardiovascular health. With a total of 4 patents to his name, his work focuses on improving methods for diagnosing and treating heart conditions.
Latest Patents
One of his latest patents is titled "System and method for determining the microvascular resistance reserve." This invention relates to a method for determining the microvascular resistance reserve (MRR) in the myocardium perfused by either a normal or a stenotic coronary artery in human patients. The method involves measuring blood flow and blood pressure during rest conditions and maximum hyperemia to calculate the MRR.
Another significant patent is "Catheter systems and methods for performing a destruction of a body obstruction." This invention describes a catheter system designed to perform body obstruction destruction. The catheter includes a shaft with fluid lumens and exit openings, allowing for the delivery of fluid at a predetermined pressure to effectively destroy obstructions.
Career Highlights
Throughout his career, Bernard De Bruyne has worked with several prominent companies in the medical field, including Hexacath and Coroventis Research AB. His expertise in catheter technology and cardiovascular diagnostics has positioned him as a key figure in medical innovation.
Collaborations
He has collaborated with notable professionals in his field, including Nico H. J. Pijls and Nico Pijls. These collaborations have further enhanced the impact of his inventions on medical practices.
Conclusion
Bernard De Bruyne's contributions to medical technology through his patents demonstrate his commitment to advancing cardiovascular health. His innovative methods and systems continue to influence the field and improve patient outcomes.